Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COR-1 Anti-ß1 Receptor Antibody Cyclopeptide in Heart Failure (Phase II)
DRKS00003149Phase 2Recruiting
- Sponsor
- Corimmun GmbH
- Start
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Mibenratide in dilated cardiomyopathy (DCM), heart failure (HF), sponsored by Corimmun GmbH. Started Jul 2011; status: recruiting.
02
Drugs
Mibenratide
03
Conditions
dilated cardiomyopathy (DCM)heart failure (HF)
Beyond the preview
Go deeper on DRKS00003149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003149.